Phototherapy Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Conventional Phototherapy Equipment LED Phototherapy Equipment Fiberoptic Phototherapy Equipment), By Application (Neonatal Jaundice Skin Diseases), Regional Insights and Forecast to 2035

Phototherapy Equipment Market Overview

The Global Phototherapy Equipment Market size is projected at USD 836.49 Million in 2026 and USD 885.93 Million in 2027, and is expected to reach USD 1,402.48 Million by 2035, growing at a CAGR of 5.91%.

The global Phototherapy Equipment Market had approximately 398.7 million units value in 2023 with installed base exceeding 500,000 clinical and home devices globally. The LED‑based devices captured about 48.2 % of global phototherapy units share and conventional fluorescent units held roughly 49.1 % of device volume in 2023. The neonatal jaundice application segment accounted for about 40 % of global volume installations.

In the USA market, phototherapy equipment reached device installation value of about 181.6 million USD equivalent and represented roughly 32.7 % of global share in 2023. The LED‑based phototherapy units comprised approximately 48.34 % of U.S. installed base in 2023, overtaking conventional devices.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Neonatal jaundice affects approximately 60% of full-term newborns and 80% of preterm newborns, sustaining strong demand for phototherapy equipment across neonatal intensive care units, maternity hospitals, pediatric departments, and specialized newborn care facilities.
• Major Market Restraint: Approximately 80% of neonatal jaundice cases can occur among preterm infants, but phototherapy accessibility remains uneven across lower-resource healthcare settings, limiting equipment utilization despite the substantial clinical requirement for effective bilirubin management.
• Emerging Trends: LED phototherapy continues gaining preference as modern systems can reduce electricity consumption by approximately 50% compared with conventional lighting technologies while offering longer operating life, lower heat generation, and more targeted therapeutic light delivery.
• Regional Leadership: North America accounts for approximately 35% of phototherapy equipment demand, supported by advanced neonatal care infrastructure, high hospital equipment penetration, established dermatology services, and widespread adoption of LED-based phototherapy technologies.
• Competitive Landscape: Philips holds approximately 23% market share, while GE Healthcare accounts for approximately 17%, indicating that the 2 prominent participants collectively represent about 40% of the phototherapy equipment market.
• Market Segmentation: Neonatal jaundice represents approximately 65% of phototherapy equipment applications, while skin-disease treatment accounts for approximately 35%, reflecting substantial utilization of phototherapy systems for bilirubin reduction alongside dermatological treatment requirements.
• Recent Development: LED-based systems represent approximately 55% of phototherapy equipment adoption, reflecting manufacturers' increasing emphasis on energy-efficient light sources, improved irradiance control, longer device operating life, reduced heat production, and simplified clinical maintenance.

Phototherapy Equipment Market Latest Trends

Phototherapy Equipment Market Trends in 2023–2025 show LED dominance, with LED units accounting for 48–55% of new installations and cutting energy use by 30–60% versus fluorescent systems that typically draw 200–400 W per device; leading LED bassinets operate at 70–110 W with irradiance stability within ±10%. Narrowband UVB at 311–313 nm represented 60–68% of dermatology treatment sessions, while targeted excimer solutions at 308 nm grew to 12–18% of clinic procedures.

NICU adoption of fiber‑optic phototherapy blankets covered 38–46% of facilities, with measured bilirubin reduction rates improving by 20–35% within 24–48 hours. Digital dosimetry, IoT uptime tracking above 97%, and UV sensors with 1–5 mW/cm² resolution enabled dose accuracy improvements of 15–25%. Teledermatology protocols linked to phototherapy scheduling rose in 28–36% of hospital networks.

How is technological advancement driving the Phototherapy Equipment Market?

Technological advancement is driving the Phototherapy Equipment Market through the adoption of LED-based systems, fiber-optic devices, IoT-enabled monitoring, and AI-assisted dose optimization. LED phototherapy equipment now accounts for nearly half of global installations due to lower energy consumption and improved treatment efficiency. Smart phototherapy systems with digital dosimetry, UV sensors, and remote treatment tracking enhance dose accuracy, patient safety, and clinical outcomes while supporting both hospital and homecare applications.

Phototherapy Equipment Market Dynamics

DRIVER

"Rising neonatal hyperbilirubinemia cases and dermatology treatment volumes"

Neonatal jaundice affects 60–80% of newborns globally and up to 85–90% of preterm infants, creating continuous demand for blue‑light phototherapy cradles and fiber‑optic blankets across 12,000–15,000 NICUs worldwide. Dermatology workloads also underpin adoption: psoriasis prevalence ranges from 1.5–3.0% of adults, vitiligo affects 0.5–2.0%.

RESTRAINT

"High preference for refurbished and legacy fluorescent systems in cost‑sensitive settings"

Across lower‑income procurement cycles, 25–40% of acquisitions involve refurbished phototherapy towers, delaying fleet renewal by 3–5 years and limiting LED penetration to 45–55% of new placements in these markets. Fluorescent tubes require replacement every 800–1,200 hours, yet audit data show 18–28% of sites extend usage >1,500 hours, causing 10–20% drops .

OPPORTUNITY

"Expansion of home‑use phototherapy and connected care pathways"

Home‑use narrowband UVB hand‑helds and panels grew to 22–30% of total dermatology device shipments, while payer authorizations expanded in 10–14 large markets, cutting clinic visits by 2–3 per patient per month and saving 40–60 minutes of travel time per session. Remote protocols using smartphone imaging achieve 85–92% diagnostic concordance with in‑clinic grading .

CHALLENGE

"Dose‑safety compliance, standardization, and workflow constraints"

Regulatory dose limits require strict management of cumulative UV exposure; audits indicate 7–11% of sites record at least 1 out‑of‑tolerance event per 1,000 sessions due to sensor drift of 2–5% or improper patient distance by 3–8 cm. Erythema risk management compels patch‑testing in 100% of first‑time NB‑UVB patients and shielding for 100% of eyes and genitals, adding 5–10 minutes per setup.

Why is Demand increasing for the Phototherapy Equipment Industry?

Demand for the Phototherapy Equipment Industry is increasing due to the rising incidence of neonatal jaundice, growing dermatology treatment volumes, and expanding home-based healthcare services. Hospitals and clinics are increasingly adopting LED and portable phototherapy systems to improve treatment efficiency and patient accessibility. The growing use of connected care solutions, expanding home-use devices, and greater awareness of non-invasive treatment options are further accelerating market growth worldwide.

Phototherapy Equipment Market Segmentation

The Phototherapy Equipment Market is segmented by product type and application. By type, LED phototherapy equipment held approximately 48 % of device share in 2023 showing rapid growth; conventional phototherapy equipment contributed around 49 % share; fiber optic phototherapy equipment provided 2–3 % of unit deployment.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Conventional Phototherapy Equipment: Conventional phototherapy equipment holds approximately 49.1% market share, making it one of the largest product segments. These systems use fluorescent lamps or traditional light sources to deliver therapeutic blue-light wavelengths, commonly around 460 nm, for neonatal jaundice treatment. Conventional devices remain widely installed in hospitals, maternity centers, and neonatal intensive care units due to their established clinical performance, availability, and compatibility with existing healthcare infrastructure.

LED Phototherapy Equipment: LED phototherapy equipment accounts for approximately 48.2% market share and is gaining strong adoption due to lower energy consumption, reduced heat generation, longer operational life, and improved treatment efficiency. Modern LED systems typically operate within the 450 nm to 470 nm wavelength range, supporting effective bilirubin reduction. These devices are increasingly preferred in neonatal intensive care units, hospitals, and homecare settings because of their reliability and advanced irradiance control features.

Fiberoptic Phototherapy Equipment: Fiberoptic phototherapy equipment represents approximately 2.7% market share and is primarily used for neonatal jaundice management where continuous skin-contact treatment is required. These systems deliver therapeutic light through flexible fiberoptic cables connected to pads or blankets, allowing infants to receive treatment while being held or fed. Their portability, reduced light exposure, and suitability for homecare applications continue to support adoption in specialized healthcare settings.

BY APPLICATION

Neonatal Jaundice: Neonatal jaundice represents a major application for phototherapy equipment, particularly during the first 7 days after birth. Approximately 60% of full-term newborns and 80% of preterm newborns develop visible jaundice. Phototherapy systems commonly use blue light near 460 nm to convert bilirubin into forms that can be eliminated more easily. LED, conventional, and fiberoptic phototherapy devices are widely deployed in neonatal intensive care units, maternity hospitals, pediatric departments, and newborn care centers.

Skin Diseases: Skin disease applications account for approximately 40% market share in the Phototherapy Equipment Market, driven by increasing treatment demand for psoriasis, vitiligo, eczema, and dermatitis. Narrowband ultraviolet-B phototherapy commonly operates near 311 nm and is frequently administered 2 to 3 times per week depending on clinical requirements. Dermatology clinics and hospitals are increasingly adopting targeted and whole-body phototherapy systems to manage inflammatory skin conditions, support immune regulation, and improve repigmentation outcomes.

Which Segment is Growing Faster in the Phototherapy Equipment Market?

The LED phototherapy equipment segment is growing the fastest in the Phototherapy Equipment Market, supported by superior energy efficiency, longer operational life, and improved therapeutic performance. LED devices accounted for approximately 48% of global device share and continue to replace conventional systems. By application, dermatology represents the largest usage segment, while neonatal jaundice remains a major growth area due to increasing demand for advanced treatment solutions.

Phototherapy Equipment Market Regional Outlook

Regional performance varied: North America led with roughly 39 % of global device share, Europe followed with about 29 %, Asia‑Pacific held around 24 %, and Middle East & Africa covered approximately 8 %. North America installations totaled over 220 million device units in 2024, Europe over 190 million, Asia‑Pacific 145 million, MEA about 50 million.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 35% of the global market, supported by strong demand from construction, renovation, and infrastructure development activities. The region benefits from well-established recycling systems that ensure a consistent supply of gypsum for wallboard, cement, and specialty applications. Growing investment in sustainable construction materials and efficient processing technologies continues to strengthen market adoption across multiple end-use industries.

The market is further supported by increasing residential development, commercial renovations, and modernization of existing buildings. Expanding use of recycled gypsum, improvements in material recovery from construction waste, and growing preference for environmentally responsible building materials continue to reinforce long-term market growth while supporting resource efficiency and circular economy initiatives.

Europe

Europe holds 26.6% of the global market, driven by strict environmental regulations, extensive renovation activities, and increasing adoption of reclaimed gypsum in construction materials. The widespread use of synthetic and recycled gypsum across wallboard, plaster, and cement manufacturing reflects the region's commitment to sustainable building practices and efficient resource utilization.

Growing demand for energy-efficient buildings, infrastructure modernization, and environmentally compliant construction products continues to support market expansion. Manufacturers are increasingly focusing on recyclable materials, improved production efficiency, and sustainable supply chains to meet evolving construction standards and reduce the environmental impact of building materials.

Asia-Pacific

Asia-Pacific represents 34.6% of the global market, making it the largest regional contributor due to rapid urbanization, expanding commercial construction, and increasing demand for modern building materials. The growing integration of synthetic gypsum into wallboard, cement, and agricultural applications has strengthened regional production capacity while supporting sustainable industrial development.

The region continues to benefit from rising residential construction, infrastructure investments, and industrial expansion. Increasing adoption of gypsum-based products in interior construction, improved collection and processing systems, and growing awareness of sustainable construction practices are further enhancing market development across diverse end-use industries.

Middle East & Africa

Middle East & Africa accounts for 10.1% of the global market, supported by large-scale infrastructure developments, social housing projects, and increasing demand for gypsum-based construction materials. Rising use of drywall systems and gypsum products in commercial and residential buildings is contributing to broader market expansion throughout the region.

Growing investment in modern construction technologies, improved cement production processes, and expanding urban development projects continue to drive demand. The market is also benefiting from increasing awareness of sustainable building materials, stronger construction activity, and ongoing improvements in regional manufacturing and distribution capabilities.

Which Region Dominates the Phototherapy Equipment Industry?

North America dominates the Phototherapy Equipment Industry due to its advanced healthcare infrastructure, high adoption of LED-based phototherapy devices, and significant investment in neonatal and dermatology care. The region accounted for the largest share of global installations, supported by strong healthcare spending, rapid adoption of innovative treatment technologies, and the presence of leading medical device manufacturers. Continuous product innovation further strengthens North America's market leadership.

List of Top Phototherapy Equipment Market Companies

• Philips Lighting Holding B.V.
• Phoenix Medical Systems Pvt. Ltd.
• Nice Neotech Medical Systems Pvt. Ltd.
• National Biological Corporation
• Herbert Waldmann GmbH & Co. Kg
• Honle UV America, Inc.
• Atom Medical Corporation
• Solarc Systems, Inc.
• The Daavlin Company, Inc.
• ArjoHuntlleigh, Inc. (Gentinge Group)
• GE Healthcare, Inc.
• Natus Medical Incorporated
• Favoro Health Projects SpA

Top Two Companies With Highest Market Share

• Philips Lighting Holding B.V. – 23%: Philips Lighting Holding B.V. holds approximately 23% of the global phototherapy equipment market, supported by more than 56,000 installed units worldwide and a strong position across neonatal and clinical phototherapy applications.
• GE Healthcare, Inc. – 17%: GE Healthcare, Inc. holds approximately 17% of the global phototherapy equipment market, with about 43,000 devices operating across more than 80 countries, giving the company the second-highest reported share.

Investment Analysis and Opportunities

Investment activity in the Phototherapy Equipment Market Market shows capital deployment in R&D and product expansion. In 2023, industry investment totaled over 150 million USD in new device platforms, representing 12 % of total medical device R&D. Approximately 28 % of venture funding in neonatal devices was allocated to LED mobile systems.

Expansion opportunities exist in Asia‑Pacific neonatal and homecare segments, where installations grew by 60 % combined in 2022–2023. Regions such as India and China saw unit installations rise from 20 million to 35 million units between 2021 and 2023, indicating investment opportunity.

New Product Development

Manufacturers have introduced multiple innovative phototherapy product lines in 2023–2025. LED mobile units with adjustable wavelength control have increased usage by 28 % share in 2023. Battery‑powered portable neonatal LED blankets launched in 2023 gained 22 % homecare adoption.

Smart phototherapy devices with IoT connectivity and treatment tracking represented 30 % of new device launches in 2023. AI‑integrated LED units that adjust irradiance based on skin pigment were rolled out in 15 countries in 2024, capturing 12 % of skin‑treatment installations. Devices offering remote controller interfaces for ambulatory use saw homecare share rise by 18 %.

Five Recent Developments

• LED : mobile phototherapy device shipments rose by 28 % share globally in 2023, expanding leadership in ambulatory units.
• Homecare LED: biliblankets adoption increased by 22 % share in 2023 compared to 2021 baseline.
• Smart : connected phototherapy units with IoT tracking comprised 30 % of all new products launched in 2024.

• Fiber‑optic: neonatal devices increased type share from 2 % to 2.6 % in 2023, following new rechargeable models.
• In India and China: combined installations grew from 20 million to 35 million device units from 2021 to 2023, pushing Asia‑Pacific share to 24 %.

Report Coverage of Phototherapy Equipment Market

This Phototherapy Equipment Market Report covers detailed quantitative analysis of installed device units, segmentation by product type and application. It includes unit shipment statistics across LED phototherapy equipment (48 % share), conventional equipment (49 %), and fiber optic units (2.6 %) as of 2023.

End‑user segmentation includes hospitals and clinics (81.8 %) and homecare settings (18.2 %). Regional coverage spans North America (39 % share), Europe (29 %), Asia‑Pacific (24 %) and Middle East & Africa (8 %), with per‑country unit figures such as USA 204 million units, Canada 16 million, China 35 million, India 25 million, Europe lead countries UK/Germany/France combined over 70 % of regional share.

Phototherapy Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 836.49 Million in 2026
Market Size Value By	USD 1,402.48 Million by 2035
Growth Rate	CAGR of 5.91%.% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Conventional Phototherapy Equipment LED Phototherapy Equipment Fiberoptic Phototherapy Equipment By Application : Neonatal Jaundice Skin Diseases
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample